Geriatric medicine in 2026 has been revolutionized by "Organ-Aging" maps, which use patient-specific organoids to predict how individual organs will age over the next decade. By analyzing the metabolic decline in a liver or heart spheroid, clinicians can prescribe targeted lifestyle and therapeutic interventions to slow down the biological clock. This move toward "Preventive Longevity" is a...
The global Bio-Micro-Electro-Mechanical Systems (BioMEMS) market in 2026 has reached a significant milestone, with a projected valuation of $6.53 billion as it continues its steady climb toward $35 billion by 2035. While the concept of miniaturized medical devices has existed for years, 2026 is the year where "Lab-on-a-Chip" (LOC) platforms have transitioned from expensive research tools to...
The DNA sequencing and next-generation sequencing (NGS) market is expanding rapidly due to increasing demand for precision medicine, genomics research, and clinical diagnostics.Market which was USD 13.82 billion in 2021, would rocket up to USD 50.04 billion by 2029, and is expected to undergo a CAGR of 17.45% during the forecast period 2022 to 2029. Growth is...
The future of hidradenitis suppurativa (HS) care is shaped by emerging technologies like AI-driven drug discovery and personalized treatment strategies. These innovations promise to uncover new targets, tailor therapies to individual patients, and address unmet needs, driving the HS market’s growth and redefining standards of care.
AI is accelerating drug development. Machine learning...
Market Overview
The global genotyping market size was valued at USD 18.58 billion in 2024 and is projected to grow from USD 21.24 billion in 2025 to reach USD 61.96 billion in 2033, growing at a CAGR of 14.32% during the forecast period (2025–2033). The market is being propelled by technological advances, falling DNA sequencing costs, and expanding...
The global human microbiome market size is experiencing remarkable expansion, driven by growing research interest and advancements in microbiome-based therapeutics. According to industry insights, the human microbiome market is projected to reach US$ 4.84 billion by 2031, rising from US$ 1.07 billion in 2023. This impressive growth reflects a robust compound annual growth rate (CAGR) of 20.8%...
The prostate health market has gained significant attention over the past decade due to the increasing prevalence of prostate-related disorders, particularly among aging male populations. Conditions such as benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer are becoming more common worldwide, driving the demand for advanced diagnostic tools, effective treatments, and...
Using Pharmacogenomics to Predict Drug Response
The concept of Personalized medicine in Schizophrenia hinges on the ability to predict how an individual will respond to a specific treatment before it is administered. Pharmacogenomics, the study of how genes affect a person's response to drugs, is becoming a reality. Genetic tests can now identify variations in liver enzymes (like...
The Healthcare Digital Twin is paving the way for hyper-personalized medicine by offering clinicians a virtual testing ground for individual patients. Creating a patient-specific digital human twin involves synthesizing a massive amount of individualized data—including multi-omics data (genomics, proteomics), detailed physiological measurements, and even lifestyle metrics—to...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china